CNBC's "Fast Money" Podcast Summary
Episode: Checking In On The Housing Market… And The Future of Pharma & Health Care
Release Date: February 18, 2025
Hosts: Melissa Lee, Dominic Cheung, Carter Worth
Panelists: Dan Nathan, Guy Adami, Julie Beal, Katerina Simonetti

1. Introduction and Market Overview

The episode kicks off with Dominic Cheung and Carter Worth introducing the day's main topics—housing market challenges, the future of the pharma and healthcare sectors, and significant movements in major stocks like Toll Brothers, Alibaba (BABA), Wynn Resorts, and Meta Platforms (META).

Notable Quote:

• Dominic Cheung [01:03]: "Shares of Toll Brothers sinking as you can see after the company's latest earnings report that after a dismal day overall for the builders, we're going to dig in on the numbers and bring you the trade on the housing space."

2. Housing Market Analysis

Toll Brothers Earnings Report:

• Diana Olick [02:23]: Describes Toll Brothers' Q1 performance as "kind of an ugly first quarter," noting missed top and bottom-line expectations.
• Key Points:
  • Revenue down 5% YoY.
  • CEO Doug Yearley attributes misses to impairments and delays in property sales.
  • Reaffirms full-year guidance despite current headwinds.
  • Concerns about tariffs affecting homebuilder sentiment.

Panel Discussion:

• Guy Adami [04:40]: Suggests that higher interest rates are impacting homebuilders more than tariffs.
  • Quote: "Higher rates are starting to have an impact."
• Julie Beal [05:49]: Highlights that higher-end builders like Toll Brothers have better visibility compared to entry-level builders, who are more economically sensitive.
  • Quote: "Affordability remains a very large problem in the home sector."

Technical Analysis:

• Katerina Simonetti [06:45]: Notes the S&P 500 home building sub-industry is down 30% from its September peak, indicating a bearish reversal.
  • Quote: "All of these stocks qualify as bullish to bearish. Reversal sells and the news out with Toll Brothers doesn't help the situation."

3. Broader Market Trends

Despite negative sentiments around certain sectors, major indices like the S&P 500, Nasdaq, and Dow are approaching or reaching record highs.

Discussion Points:

• Katerina Simonetti [09:47]: Observes that the market's recent positive performance is unusual for February, attributing it to factors like potential war resolutions and optimistic investor sentiment.
  • Quote: "Market seems to be quite opportunistic, optimistic."
• Dominic Cheung [10:32]: Predicts two rate cuts in 2025, potentially in May and September, influenced by a data-driven Federal Reserve approach.
  • Quote: "We're expecting two rate cuts this year, perhaps one in May and one in September."

4. Impact of Executive Orders and Tariffs

Executive Orders Signed by President Trump:

• Megan Casella [17:06]:
  • Expansion of access to fertility treatments.
  • Commitment to "radical transparency" in government programs and contracts.
  • Potential increase in tariffs on cars and pharmaceuticals to 25%.
  • Assurance of minimal concern over federal employee layoffs.

Investor Sentiment:

• Dan Nathan [19:12]: Notes that despite low investor sentiment, markets are reaching record highs, suggesting the market has "figured out how to sort of deal with this and handicap it."
  • Quote: "The market doesn't seem to care."

5. Stock Highlights: Intel and Alibaba

Intel (INTC):

• Guy Adami [21:17]: Discusses Intel's potential breakup amidst interest from Broadcom and Taiwan Semi, driving the stock up 36% year-to-date.
  • Quote: "These sorts of things without a CEO in place are probably pretty hard to navigate."
• Katerina Simonetti [23:05]: Analyzes Intel's technicals, suggesting a possible upward movement to around $30-$31 but advises caution.
  • Quote: "If I were in this stock and it caught this move, I would be cutting it back by half above 30."

Alibaba (BABA):

• Guy Adami [26:06]: Highlights Alibaba's surge to three-year highs following founder Jack Ma's appearance with President Xi Jinping, signaling renewed support from Beijing.
  • Quote: "The story of Apple intelligence, the story of US Multinationals going in and partnering with Alibaba and Baidu, to me means there's more room to run."
• Katerina Simonetti [29:20]: Suggests Alibaba has significant potential for recovery, as it remains below its peak despite recent gains.
  • Quote: "If you were to look at the Hang Seng, we're right back to the penny to that October 7 high. Whereas BABA is through the high, the presumption is that there's room to run."

6. Pharma and Healthcare Sector Insights

Panel Discussion:

• Mark Cuban's Involvement:
  • Angelica Peebles [31:19]: Reports on Mark Cuban's Cost Plus Drugs initiative, aiming to reduce drug prices by selling generics at cost plus a 15% markup.
  • Mark Cuban [31:19]: Expresses success with generics but acknowledges challenges in scaling to branded drugs.
  • Katerina Simonetti [31:47]: Emphasizes the need to expand insurance coverage to influence major pharmaceutical companies' decisions.

Investment Perspective:

• Julie Beal [33:29]: Cautious about investing directly in pharma companies due to uncertainties like tariffs and PBM (Pharmacy Benefit Managers) dynamics. Prefers investing in companies serving the pharma industry.
  • Quote: "The outlook right now is pretty uncertain and I don't view it as a super investable class."
• Dan Nathan [34:02]: Identifies specific pharma stocks like Gilead and Johnson & Johnson (J&J) as potential value investments despite broader sector challenges.
  • Quote: "Gilead is within a few dollars of an all-time high made 10 years ago. I think analysts are way off size."

7. Technical Analysis of Overseas Investing

Global Markets Performance:

• Katerina Simonetti [41:17]: Highlights that global markets like MSCI World and Stoxx 600 are outperforming U.S. indices, suggesting opportunities for overseas investments.
  • Quote: "The MSCI World index is up 5% in 2025. The Stoxx 600 in Europe is up nearly 10%."

Technical Insights:

• Katerina Simonetti [42:51]: Analyzes the MSCI All Country World Index versus the same index excluding U.S. stocks, indicating potential for European and Asian markets.
  • Quote: "The MSCI x the US has been underperforming since 09 low but it did outperform in 2001-2007."

8. Calls of the Day: Wynn Resorts and Hims & Hers

Wynn Resorts (WYNN):

• Dan Nathan [37:22]: Supports Wynn Resorts' recent surge, citing favorable analyst upgrades and growth potential in Macao and U.S. markets.
  • Quote: "This stock is up another 2.75% today after last week's earnings pop."
• Guy Adami [37:55]: Notes Wynn's reliance on Macao revenues and potential US market growth.
  • Quote: "The rally here could keep on going the way that BABA has if we got some sense that there's going to be more stimulus."

Hims & Hers (HIMS):

• Julie Beal [39:05]: Advises caution, highlighting high valuation (110x forward earnings) and potential regulatory hurdles.
  • Quote: "Part of it, too, is a regulatory issue. What will the Trump administration's viewpoint on compounders be?"

Technical Analysis:

• Katerina Simonetti [39:56]: Points out that Hims & Hers is trading well above its moving average with increased volatility, suggesting potential price corrections.
  • Quote: "It's some 150% above the 150 moving average. It's also, to Julie's point, volatile."

9. Final Trades and Closing Remarks

Closing Trades:

• Julie Beal [44:41]: Recommends Celsius (CELU) as a potential long-term investment despite short-term challenges.
  • Quote: "I think the bad news is past us and for long-term investors could be a good one."
• Katerina Simonetti [44:48]: Suggests silver as a valuable commodity investment, anticipating a breakout.
  • Quote: "Silver. Lagging gold. But its time is now. We think it breaks out here."

Closing Remarks:

• Carter Worth [45:14]: Concludes the episode by summarizing key trades and highlighting upcoming segments, including insights on international investments and future stock movements.

Key Takeaways:

1. Housing Market Struggles: Toll Brothers' disappointing earnings reflect broader challenges in the housing market, particularly for entry-level builders. However, high-end builders like Toll Brothers maintain better visibility and resilience.

2. Market Optimism Amid Uncertainty: Despite negative sentiments in specific sectors, major indices are reaching record highs, driven by optimistic investor behavior and potential rate cuts by the Federal Reserve.

3. Impact of Executive Orders: Recent executive orders, especially those related to tariffs on cars and pharmaceuticals, introduce both short-term headwinds and long-term opportunities in affected sectors.

4. Stock-Specific Movements: Significant volatility in stocks like Intel and Alibaba highlights the dynamic nature of the tech sector, influenced by corporate strategies and geopolitical factors.

5. Pharma Sector Challenges: While pharma remains a complex investment landscape due to regulatory and pricing challenges, select companies like Gilead and J&J show potential value amidst broader uncertainties.

6. Overseas Investment Opportunities: Global markets, particularly in Europe and Asia, are outperforming the U.S., presenting viable opportunities for portfolio diversification.

7. Strategic Stock Picks: Wynn Resorts and Hims & Hers offer contrasting investment stories, with Wynn showing growth potential and Hims & Hers posing higher risks due to valuation and regulatory factors.

8. Final Trades Recommendations: Celsius and silver emerge as notable final trades, suggesting avenues for both growth and value protection.

Notable Quotes with Timestamps:

• Dominic Cheung [00:14]: “Financial strategies to help support what truly matters to you.”
• Diana Olick [02:23]: “Although demand has remained healthy in many of our markets, affordability constraints and growing inventories in certain markets are pressuring sales.”
• Guy Adami [04:40]: “Higher rates are starting to have an impact.”
• Julie Beal [05:49]: “Affordability remains a very large problem in the home sector.”
• Dan Nathan [19:16]: “Investor sentiment is not great. Apparently the lowest I've seen in about a year and a half.”
• Guy Adami [21:17]: “Intel can still go higher and ... there's a gap to be filled above of that.”
• Katerina Simonetti [34:02]: “The S&P 500 pharmaceuticals is at 30-year lows.”
• Julie Beal [33:29]: “I don't view it as a super investable class. I would rather own businesses that serve pharma companies.”
• Mark Cuban [31:19]: “It's going to take a lot more to get the branded companies to move away from the big PBMs.”

This comprehensive summary captures the essence of CNBC's "Fast Money" episode from February 18, 2025, providing insights into the housing market, pharma sector, significant stock movements, and global investment opportunities, enriched with key quotes and structured for clarity.